Lijie Han

Zhejiang Provincial People's Hospital — China

Medicine · Health Sciences

20h-index943citations84works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(16), Acute Myeloid Leukemia Research(14), Acute Lymphoblastic Leukemia research(10), Gut microbiota and health(8), Lung Cancer Treatments and Mutations(7)

Publications84 total

Macular choriocapillaris perfusion area: a potential biomarker of mild cognitive impairment in patients with cerebral small vessel disease
Stroke and Vascular Neurology·2025Open Access
A cross sectional study of the diabetes mediated GGT to HDL ratio and cognitive function in older adults
Scientific Reports·2025· 2 citedOpen Access
The Composite Dietary Antioxidant Index Counteracts the Cognitive Effects of Heavy Metal Exposure
2025Open Access
Macular radial peripapillary capillary: a potential optical coherence tomography angiography biomarker of cognitive impairment in patients with internal carotid artery stenosis
Journal of Neurorestoratology·2025Open Access
Recent development in bispecific antibody immunotherapy for hematological malignancies
Critical Reviews in Oncology/Hematology·2025· 5 citedOpen Access
Bispecific antibodies in immunotherapy for acute leukemia: latest updates from the 66th annual meeting of the American society of hematology, 2024
Frontiers in Oncology·2025· 4 citedOpen Access
Thyroid Gland as a Metastatic Site for Hepatocellular Carcinoma: A Rare Case Report
OncoTargets and Therapy·2024· 1 citedOpen Access
MA17.08 Safety and Efficacy of Tifcemalimab Combined with Toripalimab in Refractory Extensive Stage Small Cell Lung Cancer
Journal of Thoracic Oncology·2024Open Access
Multi-omics analysis reveals a feedback loop amplifying immune responses in acute graft-versus-host disease due to imbalanced gut microbiota and bile acid metabolism
Journal of Translational Medicine·2024· 7 citedOpen Access
Latest results of a phase 2 study of IMM01 combined with azacitidine (AZA) as the first-line treatment in adults with higher risk myelodysplastic syndromes (MDS).
Journal of Clinical Oncology·2024· 1 cited
WITHDRAWN: SPOP Promotes Acute Myeloid Leukemia Initiation and Development Through miR-183-Mediated METAP2 Inhibition
Molecular Therapy — Nucleic Acids·2024Open Access
Bispecific antibodies targeting CD20xCD3 in immunotherapy for adult B-cell lymphoma: insights from the 65th American Society of Hematology 2023 annual meeting
Expert Opinion on Biological Therapy·2024· 2 cited
Clinical features and outcomes of unresectable locally advanced non-small cell lung cancer with uncommon EGFR Mutations: A retrospective multi-center Chinese study
Research Square (Research Square)·2024Open Access
Bispecific antibodies in immunotherapy for adult acute leukemia: latest updates from the 65th American Society of Hematology 2023 Annual Meeting
Expert Opinion on Biological Therapy·2024· 3 cited
A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma
Journal of Translational Medicine·2024· 24 citedOpen Access
BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1
Advanced Science·2023· 26 citedOpen Access
Determining the prognosis of Lung cancer from mutated genes using a deep learning survival model: a large multi-center study
Cancer Cell International·2023· 4 citedOpen Access
Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Higher Risk Myelodysplastic Syndromes (MDS)
Blood·2023· 9 cited
Bispecific antibodies as monotherapy or in combinations for hematological malignancies: latest updates from the EHA 2023 annual meeting
Expert Opinion on Biological Therapy·2023· 3 cited
Teclistamab in the Treatment of Multiple Myeloma: Latest Updates from the 2023 EHA Annual Meeting
Annals of Hematology & Oncology·2023Open Access
page 1 of 5Next →

Frequent Co-authors

Zhongxing Jiang(13), Qifa Liu(12), Zhiping Fan(11), Fen Huang(10), Jie Peng(9), Jifeng Yu(9), Li Xuan(8), Yongping Song(7), Na Xu(6), Jing Sun(6), Hua Jin(5), Haiyan Zhang(5), Weijie Cao(5), Youwei Zhu(4), Minmin Shi(4), Lizhi Zhou(4), Min Dai(4), Jian Zhou(4), Sijian Yu(4), Hui Liu(4)